Asthma Yardstick Update: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma

Ann Allergy Asthma Immunol. 2018 Dec;121(6):660-661. doi: 10.1016/j.anai.2018.08.018. Epub 2018 Aug 30.

Authors

John J Oppenheimer¹, Larry Borish²

Affiliations

¹ Department of Internal Medicine, New Jersey Medical School, Pulmonary and Allergy Associates, Morristown, New Jersey. Electronic address: [email protected].
² Asthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia.

PMID: 30172715
DOI: 10.1016/j.anai.2018.08.018

No abstract available

MeSH terms

Anti-Asthmatic Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma / drug therapy*
Humans
Interleukin-13 / antagonists & inhibitors
Interleukin-4 / antagonists & inhibitors
Interleukin-5 / antagonists & inhibitors

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
IL4 protein, human
IL5 protein, human
Interleukin-13
Interleukin-5
Interleukin-4
benralizumab
tezepelumab